A judge criticized Trump's former adviser Flynn for lying to the FBI in a probe into Russian meddling in the 2016 election, and delayed sentencing until Flynn has finished helping prosecutors.
Business & Financial News, U.S & International Breaking News
Uber gets approval from Pennsylvania to resume self-driving testing
Uber Technologies Inc received approval from Pennsylvania to resume self-driving car testing on public roads this week, state records show, nine months after it suspended the program following a deadly accident in Arizona.
Judge mulls using monitor to oversee CVS during court process
A federal judge said on Tuesday that he was considering using a court-appointed monitor to make sure CVS Health Corp refrains from fully integrating with insurer Aetna while he examines the companies' settlement with the government.
New Hampshire physician assistant guilty of Insys opioid kickback scheme
A former physician assistant in New Hampshire was convicted on Tuesday of charges that he accepted nearly $50,000 in kickbacks from Insys Therapeutics Inc in exchange for prescribing its addictive fentanyl spray.
FedEx cuts 2019 view on European softness, global trade cool-down
U.S. package delivery company FedEx Corp on Tuesday cut its 2019 forecast after Europe's economy weakened and trade skirmishes exacerbated a slowdown in China, sending its shares tumbling 6 percent in after-hours trade.
Trump bans 'bump stocks' used in Las Vegas mass shooting
The Trump administration on Tuesday banned the high-power gun attachments of the type used in last year's Las Vegas shooting massacre of 58 people, giving the owners of "bump stocks" 90 days to turn in or destroy the devices and blocking owners from being able to register them.
FDA panel backs prescribing opioid overdose reversal drug along with painkillers
An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal drug, naloxone, along with addictive painkillers.
Exp: Dec 18
Exp: Dec 18
Exp: Dec 18
Home healthcare provider Civitas Solutions Inc said on Tuesday it would sell itself to funds advised by Centerbridge Partners L.P. in a deal valued at $641 million.
Have a news tip?
Reuters provides several ways to securely and confidentially share information and materials with our journalists.LEARN MORE ››